NCT01838967 - A Drug Interaction Study of Cilnidipine and Valsartan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

October 31, 2013

Conditions

Healthy

Interventions

DRUG

C - V - C+V

Drug will be administered to according to C - V - C+V sequence for 3 period.

DRUG

C - C+V - V

Drug will be administered to according to C - C+V - V sequence for 3 period.

DRUG

V - C - C+V

Drug will be administered to according to V - C - C+V sequence for 3 period.

DRUG

V - C+V - C

Drug will be administered to according to V - C+V - C sequence for 3 period.

DRUG

C+V - C - V

Drug will be administered to according to C+V - C - V sequence for 3 period.

DRUG

C+V - V - C

Drug will be administered to according to C+V - V - C sequence for 3 period.

Trial Locations (1)

Seoul National University Hospital, Jongno-gu